Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G van der Zee

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|November 29, 1996
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnoverK C Wolthers, G Bea, A Wisman, et al.
Gynecologic Oncology|April 20, 2016
Improved outcomes due to changes in organization of care for patients with ovarian cancer in the NetherlandsF A Eggink, C H Mom, R F Kruitwagen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinomaH J Arts, D Katsaros, E G de Vries, et al.
Human Mutation|September 9, 2014
High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumorsAna M Ferreira, Iina Tuominen, Krista van Dijk-Bos, et al.
The Lancet. Oncology|July 20, 2010
Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trialMarian J E Mourits, Claudia B Bijen, Henriëtte J Arts, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancerJohn H Maduro, Helena A den Dekker, Elisabeth Pras, et al.
Gastroenterology|May 29, 2001
Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC formsY Wu, M J Berends, J G Post, et al.
International Journal of Cancer|April 6, 2001
MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancerM J Berends, H Hollema, Y Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2017
Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratificationF A Eggink, C H Mom, K Bouwman, et al.
The Lancet. Oncology|June 12, 2010
Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational studyMaaike H Oonk, Bettien M van Hemel, Harry Hollema, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|November 29, 1996
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnoverK C Wolthers, G Bea, A Wisman, et al.
Gynecologic Oncology|April 20, 2016
Improved outcomes due to changes in organization of care for patients with ovarian cancer in the NetherlandsF A Eggink, C H Mom, R F Kruitwagen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinomaH J Arts, D Katsaros, E G de Vries, et al.
Human Mutation|September 9, 2014
High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumorsAna M Ferreira, Iina Tuominen, Krista van Dijk-Bos, et al.
The Lancet. Oncology|July 20, 2010
Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trialMarian J E Mourits, Claudia B Bijen, Henriëtte J Arts, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancerJohn H Maduro, Helena A den Dekker, Elisabeth Pras, et al.
Gastroenterology|May 29, 2001
Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC formsY Wu, M J Berends, J G Post, et al.
International Journal of Cancer|April 6, 2001
MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancerM J Berends, H Hollema, Y Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2017
Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratificationF A Eggink, C H Mom, K Bouwman, et al.
The Lancet. Oncology|June 12, 2010
Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational studyMaaike H Oonk, Bettien M van Hemel, Harry Hollema, et al.
Pageof 8